Second-line chemotherapy with paclitaxel for elderly patients with advanced gastric cancer

被引：0
|
作者：
Ohba, Akihiro
Takashima, Atsuo
Nishiuchi, Takamasa
Honma, Yoshitaka
Iwasa, Satoru
Okita, Natsuko
Kato, Ken
Hamaguchi, Tetsuya
Nagashima, Kengo
Boku, Narikazu
机构：
[1] Natl Canc Ctr, Gastrointestinal Med Oncol, 1-1 Tsukiji 5 Chome, Tokyo, Japan
[2] Kagawa Univ, Fac Med, Dept Clin Oncol, Kagawa, Japan
[3] Chiba Univ, Grad Sch Med, Dept Global Clin Res, Chiba, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 04期
关键词：
D O I：
10.1200/jco.2016.34.4_suppl.108
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
108
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Impact of peripheral neuropathy induced by platinum in first-line chemotherapy on second-line chemotherapy containing paclitaxel for advanced gastric cancer.
    Otsuka, Ryo
    Iwasa, Satoru
    Yanai, Takako
    Shoji, Hirokazu
    Honma, Yoshitaka
    Okita, Natsuko
    Takashima, Atsuo
    Kato, Ken
    Hashimoto, Hironobu
    Makino, Yoshinori
    Sekiguchi, Masatoshi
    Ishizone, Yoshimasa
    Boku, Narikazu
    Yamaguchi, Masakazu
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [42] Efficacy of Nab-Paclitaxel as Second-line Chemotherapy for Unresectable or Recurrent Gastric Cancer
    Fukuchi, Minoru
    Mochiki, Erito
    Ishiguro, Toru
    Ogura, Toshiro
    Sobajima, Jun
    Kumagai, Youichi
    Ishibashi, Keiichiro
    Ishida, Hideyuki
    ANTICANCER RESEARCH, 2016, 36 (12) : 6699 - 6703
  • [43] Prognostic impact of response to second-line chemotherapy on overall survival of patients with advanced gastric cancer
    Kim, S.
    Hwang, M.
    Park, Y.
    Park, S.
    Kim, Y.
    Ryu, K.
    Lee, J.
    Park, Y.
    Kim, N.
    Park, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [44] Second-line chemotherapy in advanced bladder cancer
    Pavone-Macaluso, M
    Sternberg, C
    UROLOGIA INTERNATIONALIS, 2000, 64 (02) : 61 - 69
  • [45] The role of ramucirumab plus paclitaxel as second-line therapy after failure of nivolumab plus doublet chemotherapy in patients with advanced gastric cancer
    Jeon, Youngkyung
    Lim, Sung Hee
    Lee, Jeeyun
    Kang, Won Ki
    Jang, Jae Yeon
    Jeong, Sun Young
    Choi, Daeho
    Kim, Seung Tae
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2023, 14 (06) : 2346 - 2353
  • [46] What is a best choice at the second-line chemotherapy for advanced or recurrent gastric cancer?
    Yamamoto, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [47] Ramucirumab plus paclitaxel as second-line treatment in patients with advanced gastric cancer who previously treated with first-line nivolumab plus chemotherapy
    Jeon, Youngkyung
    Jeong, Sun Young
    Jang, Jaeyeon
    Jung, Ye Ji
    Choi, Daeho
    Hong, Joohyun
    Kim, Seung Tae
    Kang, Won Ki
    Lee, Jeeyun
    CANCER RESEARCH, 2023, 83 (07)
  • [48] A phase II study of weekly paclitaxel as second-line chemotherapy for advanced gastric cancer (CCOG0302 study)
    Kodera, Yasuhiro
    Ito, Seiji
    Mochizuki, Yoshinari
    Fujitake, Shinichi
    Koshikawa, Katsumi
    Kanyama, Yasuaki
    Matsui, Takanori
    Kojima, Hiroshi
    Takase, Tsunenobu
    Ohashi, Norifumi
    Fujiwara, Michitaka
    Sakamoto, Junichi
    Nakao, Akimasa
    ANTICANCER RESEARCH, 2007, 27 (4C) : 2667 - 2671
  • [49] Paclitaxel Carboplatin chemotherapy as a second-line chemotherapy for advanced platinum resistant urothelial cancer in Japanese cases
    Soga, Norihito
    Onishi, Takehisa
    Arima, Kiminobu
    Sugimura, Yoshiki
    INTERNATIONAL JOURNAL OF UROLOGY, 2007, 14 (09) : 828 - 832
  • [50] Second-line chemotherapy with combined docetaxel and cisplatin for patients with advanced gastric carcinoma
    Kunisaki, Chikara
    Makino, Hirochika
    Oshima, Takashi
    Nagano, Yasuhiko
    Fujii, Syoichi
    Takagawa, Ryo
    Kosaka, Takashi
    Ono, Hidetaka
    Akiyama, Hirotoshi
    Shimada, Hiroshi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 : A147 - A147
12345